Infection Control in Anaesthesia by unknown
GUIDELINES
Infection Control in Anaesthesia
Association of Anaesthetists of Great Britain and Ireland
Membership of the Working Party: Gemmell L, Chair; Birks R, President Elect; Radford P, Royal
College of Anaesthetists representative; Jeffries D, National Institute for Health and Clinical
Excellence; Ridgway G, consultant microbiologist; McIvor D, Medicines and Healthcare Products
Regulatory Authority; Executive Ofﬁcers of AAGBI, ex ofﬁcio
This is a consensus document produced by expert members of a Working Party established by the Association of
Anaesthetists of Great Britain and Ireland (AAGBI). It updates and replaces previous guidance published in
2002.
1.0. Summary
(1) A named consultant in each department of anaes-
thesia should liaise with Trust Infection Control
Teams and Occupational Health Departments to
ensure that relevant specialist standards are estab-
lished and monitored in all areas of anaesthetic
practice.
(2) Precautions against the transmission of infection
between patient and anaesthetist or between patients
should be a routine part of anaesthetic practice.
In particular, anaesthetists must ensure that hand
hygiene becomes an indispensable part of their
clinical culture.
(3) Anaesthetists must comply with local theatre infection
control policies including the safe use and disposal of
sharps.
(4) Anaesthetic equipment is a potential vector for
transmission of disease. Policies should be docu-
mented to ensure that nationally recommended
decontamination practices are followed and audited
for all reusable anaesthetic equipment.
(5) Single use equipment should be utilised where
appropriate but a sterile supplies department (SSD)
should process reusable items.
(6) An effective, new bacterial ⁄viral breathing circuit
ﬁlter should be used for every patient and a local
policy developed for the re-use of breathing circuits
in line with manufacturer’s instructions. The AAGBI
recommends that anaesthetic departments should
consider changing anaesthetic circuits on a daily basis
in line with daily cleaning protocols.
(7) Appropriate infection control precautions should be
established for each anaesthetic procedure, to include
maximal barrier precautions for the insertion of central
venous catheters, spinal and epidural procedures and
any invasive procedures in high risk patients.
2.0. Introduction
The Association of Anaesthetists of Great Britain and
Ireland (AAGBI) published guidelines in 2002 on prob-
lems relating to infection control in anaesthetic practice.
In addition to AAGBI Ofﬁcers and Council members,
representation included the Royal College of Anaesthe-
tists and the Medicines and Healthcare Products Regu-
latory Authority (MHRA). This is an updated version of
that guidance document.
Healthcare organisations now have a legal responsibility
to implement changes to reduce healthcare associated
infections (HCAIs). The Health Act 2006 provided the
Healthcare Commission with statutory powers to enforce
compliance with the Code of Practice for the Prevention
and Control of Healthcare Associated Infection (The
Code). The Code provides a framework for NHS Bodies
to plan and implement structures and systems aimed at
prevention of HCAIs. The Code sets out criteria that
mandate NHS bodies, including Acute Trusts, and which
ensure that patients are cared for in a clean environment.
Anaesthetists should be in the forefront of ensuring
that their patients are cared for in the safest possible
environment. Further advice can be obtained from the
Department of Health (DOH) website http://www.
clean-safe-care.nhs.uk.
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Healthcare providers have responsibilities under the
Health and Safety at Work Act 1974; offences against
the Act are covered by Criminal Law. The Control of
Substances Hazardous to Health (COSHH) Regulations 1999
have been considered part of the Health and Safety at Work
Act; the Act ensures that Trusts are responsible for the
health and safety of their employees and others (including
visitors and patients), and the control and management of
the risk of infection. As part of the Health Act 2006, the
Department of Health (DOH) released the Code of Practice
for the Prevention and Control of Healthcare Associated
Infections [1].
Trust Chief Executives are accountable for ensuring
that care delivered within each Trust meets relevant
standards. Trusts should have Infection Control Com-
mittees and Infection Control Teams responsible for
preparing policies and monitoring compliance with
appropriate standards. A microbiologist should be desig-
nated to provide advice on microbiological aspects of
decontamination and sterilisation. The AAGBI Working
Party recommends that a named consultant in each
Department of Anaesthesia should liaise with the Infec-
tion Control Team and the Occupational Health Depart-
ment to ensure that relevant standards are established and
monitored in all areas of anaesthetic practice.
The environment
Hospital environmental hygiene encompasses a wide
range of routine activities that are important in the
prevention of HCAI. The hospital must be visibly clean
and acceptable to patients, visitors and staff. Statutory
requirements must be met in relation to safe disposal of
clinical waste, laundry and linen. Bed occupancy should
ensure enough time between patient admissions to ensure
adequate cleaning and decontamination of the patient
area.
The Code of Practice enshrines in law the duty of
Trusts to maintain a clean and appropriate environment
for patients including the fabric of the building and related
structures. Operating theatres and associated areas should
be designed and maintained to the standards deﬁned
in Health Building Note 26, Facilities for Surgical Procedures
published in 2004. Microbiological commissioning and
monitoring of operating theatre suites should adhere to
national recommendations.
Standard precautions
Anaesthetists will be involved in the care of patients who
may harbour potentially pathogenic organisms, which
may not be obvious or readily identiﬁable. Precautions
aimed at preventing the transmission of organisms
between patient and anaesthetist or between patients
must be a routine part of anaesthetic practice.
The AAGBI recommends the use of Standard Precau-
tions, which incorporate additional safeguards for speciﬁc
procedures and patients, including single-use gloves, ﬂuid
resistant masks with a transparent face shield and gowns
[2]. Precautions are recommended for all patients regard-
less of their diagnosis or presumed infectious status and
must be implemented when there is a possibility of
contact with:
1 Blood.
2 All other body ﬂuids.
3 Non-intact skin.
4 Mucous membranes.
Preventative measures should be based on the likeli-
hood of an infectious agent being present, the nature of
the agent and the possibility of dispersion, e.g. splashing.
A standard set of precautions should be established for
every invasive procedure (see below) with additional risk
assessment of each patient to determine extra and speciﬁc
precautions that may be appropriate.
Hand hygiene
Anaesthetists must ensure that good hand hygiene becomes
an indispensable part of their clinical culture
Hand-mediated transmission is the major contributing
factor to infection associated with healthcare [3]. Effective
hand decontamination immediately before every episode
of direct patient contact will result in a signiﬁcant
reduction in the transfer of potential pathogens and a
decrease in the incidence of preventable HCAI [4].
Despite consistent advice, staff often neglect hand hygiene
when caring for patients.
At the start of every session, and when visibly soiled or
potentially contaminated, hands must be washed with
liquid soap and water. When there is no soiling, the
Hand Hygiene Liaison Group advocates that staff should
use an antimicrobial hand rub between patients or
activities [5] as this is effective and quicker. It is vital to
ensure that the whole hand and ﬁngers (particularly the
tips), are exposed to the hand rub. Antimicrobial hand
rub is not effective in preventing cross infection with
Clostridium difﬁcile.
Trusts must ensure that sinks, soap and antimicrobial
hand rubs are conveniently placed to encourage regular
use. Watches and jewellery (including dress rings
and wrist adornments) must be removed at the beginning
of each clinical session, before regular hand decontamina-
tion begins. Cuts and abrasions must be covered with
waterproof dressings, which must be changed as appro-
priate. Staff with dermatitis, psoriasis or other skin
conditions should consult with the Occupational Health
Department for further advice.
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directly tied to the clinical governance framework and
regularly reviewed under a system of audit, revision and
update.
Gloves
It is important to undertake a risk assessment regarding
the safe use of gloves. Although they may offer some
protection against inoculation with blood-borne viruses,
incorrect use of gloves could actually spread infection
between patients.
Sterile gloves must be worn for invasive procedures and
contact with sterile sites. Non-sterile examination gloves
must be worn for contact with mucous membranes, non-
intact skin and all activities that carry a risk of exposure to
blood, body ﬂuids, secretions and excretions. All blood
and body ﬂuids, substances, secretions and excretions may
be considered to be potentially infective regardless of the
perceived risk of the source.
Gloves must be worn as single-use items. They should
be put on immediately before an episode of patient
contact and removed as soon as the activity is completed,
and before contact with fomites, including curtains, pens,
clinical notes, keyboards and telephones. Gloves should
be changed between patients and between different
procedures on the same patient. Gloves must be disposed
of as clinical waste and hands should be washed or
decontaminated following the removal of gloves. It has
been demonstrated that 98% of anaesthetists’ contact with
patients’ blood could be prevented by routine use of
gloves [6].
Gloves of an acceptable quality must be available in all
clinical areas. Latex-free gloves must be available for use
for staff or patients who have an allergy or sensitivity to
rubber gloves.
Facemasks
The use of facemasks to decrease the incidence of
postoperative wound infection has been questioned
[7, 8]. However, masks with a face shield should be
worn when there is a risk of blood, body ﬂuids, secretions
and excretions splashing into the face and eyes. Masks
must also be worn by anaesthetists when carrying out a
sterile procedure under full aseptic conditions (see later).
If worn, masks should not be taken down to speak and
should be changed if they become damp or contaminated.
Masks must only be handled by the ties. Correctly ﬁtting
facemasks may also give some protection to the anaes-
thetist against inhaling infected droplets from the respi-
ratory tracts of patients with infectious respiratory
diseases.
The Working Party is aware that the wearing of masks
remains an area of contention in many Trusts and
conﬂicting evidence may be cited [9, 10]. In view of
the continuing controversy about the wearing of masks,
the Working Party suggests that local protocols should be
agreed about their use in hospitals.
Theatre caps
Theatre personnel in most UK operating theatres wear
disposable headgear although there is little evidence for
the effectiveness of this practice except for scrub staff in
close proximity to the operating ﬁeld [11]. However,
theatre caps should be worn in laminar ﬂow theatres
during prosthetic implant operations, and it is the
Working Party’s view that their general use should
continue.
Theatre suits and gowns
The skin of staff working in the operating theatre is a
major source of bacteria that have the potential for being
dispersed into the air. Clean theatre suits should be
available for all staff in theatre. Full body, ﬂuid-repellent
gowns should be worn where there is a risk of extensive
splashing of blood, body ﬂuids, secretions and excretions.
Sterile gowns should be worn when invasive procedures
are undertaken. Disposable plastic aprons are often worn
on wards in situations where there is a risk of physical
soiling of clothing in order to prevent transmission of
infection between patients.
Contaminated clothing should be changed and safely
discarded into an appropriate receptacle at the earliest
opportunity.
There is little evidence to show that wearing surgical
attire outside the theatre and returning to the theatre
without changing increases surgical wound infection
rates. With the widespread move to admission on the
day of surgery, the times when anaesthetists will have to
leave theatre have increased and repeated changing will
impact on theatre efﬁciency. Local policies must be
developed and reﬂect the necessity for ‘theatre discipline’
and allay perceived concerns of patients and visitors. Local
policies should be agreed between all theatre users and
Trusts must ensure adequate provision of appropriate
clothing. The DoH guidance on Uniforms and Work-
wear [12] also recognises that there is little evidence that
work clothes pose a signiﬁcant hazard in terms of
increased infection rates.
Shoes and overshoes
Special footwear should be worn in the operating
department and cleaned if contaminated or after every
use. Trusts should ensure that a system for cleaning
theatre footwear is in place in each theatre suite. Plastic
overshoes may increase bacterial contamination of ﬂoors
[13] and, in addition, hands become contaminated when
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recommended.
Movement within the theatre complex
To reduce airborne contamination, general trafﬁc in and
out of the operating theatre itself should be kept to a
minimum. Doors should be kept closed to ensure the
efﬁciency of the ventilation system.
Moving patients on their beds into the operating
theatre may increase the bacterial count on ﬂoors, but it is
claimed that this is of little signiﬁcance if bed linen is
changed before transfer [14]. All used linen must be
handled safely to minimise the risk of contamination of
the environment and staff. Used bed linen must be
handled with care to reduce the release of small fomite
particles into the air – bed linen should be ‘bagged’ by the
bed or patient trolley. The use of separate trolleys from
ward to transfer area and transfer area to table has not
been shown to have beneﬁt [15] although this practice
continues in many operating areas.
If entering the operating theatre itself, visitors should
change into theatre suits and wear designated footwear.
Order of patients
There should be a written hospital policy requiring
accurate printed theatre lists to be available prior to the
scheduled date. ‘Dirty cases’, i.e. patients likely to disperse
microbes of particular risk to other patients, should be
identiﬁed before surgery and theatre staff should be
notiﬁed. These patients should be scheduled last on an
operating list to minimise risk. Where this is not possible,
the Hospital Infection Society (HIS) advises that a
plenum-ventilated operating theatre should require a
minimum of 15 min before proceeding to the next case
after a ‘dirty’ operation [16].
The most probable routes for transmission of infection
between successive patients are airborne or on items and
surfaces that have been in contact with the patient.
Appropriate cleaning of the operating theatres between
all patients should be undertaken. Whenever there is
visible contamination with blood or other body materials,
the area must be disinfected with sodium hypochlorite
(according to local protocols) and then cleaned with
detergent and water. Floors of the operating room should
be disinfected at the end of each session.
Safe use and disposal of sharps
Accidental injury has long been recognised as an occu-
pational hazard in the healthcare setting. Accidental
inoculation with infected blood, however small in
amount, presents a signiﬁcant risk to anaesthetists.
In the UK, 16% of occupational injuries occurring
in hospitals are attributed to sharps injuries. These are
predominantly caused by needles and are associated
mainly with venepuncture, administration of intravenous
drugs and recapping of needles. These should be
preventable by adhering to national guidelines and agreed
standards [17]:
• Sharps must not be transferred between personnel and
handling should be kept to a minimum.
• Needles must not be bent or broken prior to use or
disposal.
• Needles and syringes must not be disassembled by hand
prior to disposal.
• Needles should not be recapped or resheathed.
• Used sharps must be discarded into an approved sharps
container at the point of use.
• The sharps container should be sealed and disposed of
safely by incineration when about two-thirds full or in
use for more than four weeks, whichever is sooner.
Sharps containers must comply with BS 7320:1990 –
‘Speciﬁcation for sharps’.
• Blunt aspirating needles should be used for drawing up
drugs.
• Needle protection devices may reduce needlestick
injuries but require further evaluation before wide-
spread use can be advised.
Preventing contamination of drugs
Drugs and ﬂuids require safe handling by anaesthetists,
who should follow local protocols for preparation and
administration to prevent contamination.
Syringes and needles are sterile, single-use items and,
after entry or connection to a patient’s vascular system
or attachment to infusions, a syringe and needle should
be considered contaminated and used only for that
patient. A syringe must not be used for multiple
patients even if the needle is changed. Before use,
prepared syringes and needles should be stored in a
clean container and syringes capped to avoid contam-
ination. After use or at the end of the anaesthetic, all
used syringes with needles should be discarded into an
approved sharps container.
Care must be taken when drawing up drugs. Single use
ampoules should be discarded after the required amount
of drug is drawn up and not re-used for subsequent
patients. Ampoules can be kept for identiﬁcation purposes
and discarded at the end of the list. Multiple-use ampoules
are not recommended.
All infusions, administration sets or items in contact
with the vascular system or other sterile body compart-
ments are for single-patient use. An aseptic technique
should be used when preparing infusions and breaks ⁄taps
in lines should be kept to a minimum. Injection ports
should be maintained with a sterile technique, kept free
of blood and covered with a cap when not in use.
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should be kept to a minimum. Three-way taps should be
avoided if practicable. Needle-free Luer injection devices
should be used to cover exposed female Luer injection
ports. These are easily cleaned before and after drug
administration, do not harbour blood in crevices and also
reduce the need for needles, resulting in a reduction of
needlestick injuries.
4.0. Anaesthetic equipment and infection
control
Items of anaesthetic equipment may become contami-
nated either by direct contact with patients, indirectly via
splashing, by secretions or from handling by staff.
Contamination is not always visible and all used pieces
of equipment must be assumed to be contaminated and
disposed of or, if reusable, undergo a process of decon-
tamination. The Code of Practice has speciﬁc require-
ments for the decontamination of surgical equipment
and other equipment used in patient care. There is a need
to designate a person who is responsible for ensuring
equipment cleanliness.
Single-use equipment
Where appropriate, single-use disposable equipment will
remove the difﬁculties of re-use and decontamination
procedures. The use of such equipment is to be encour-
aged. However, there are problems of cost, storage and
disposal of single-patient use devices, and for some
equipment there is no feasible disposable alternative.
The balance between single-use items and re-usable
equipment will require local determination based on an
assessment of patient safety, the available facilities and cost.
Packaging should not be removed until the point of use for
infection control, identiﬁcation, traceability in the case of
a manufacturer’s recall, and safety.
A multidisciplinary research team at the University of
Nottingham has carried out a study investigating the use
and re-use of single-use devices in English NHS operating
theatres. The published paper clariﬁed some of the issues
around single-use devices such as single-use equipment
that must be immediately discarded after use, e.g. suction
catheters, and some that may be re-used in the same
patient in the same episode, e.g. disposable laryngoscope
blades [18].
Decontamination
Decontamination is a combination of processes including
cleaning, disinfection and ⁄or sterilisation used to make a
re-usable item safe to be handled by staff and safe for
further use on patients. Effective decontamination of
re-usable devices is essential in reducing the risk of
infection. ‘Guidance on Decontamination’ prepared by
the MHRA and DoH provides guidelines for the safe
reprocessing of medical devices [19, 20]. It is recom-
mended that each department identiﬁes a designated
consultant who, in conjunction with the appropriate
bodies in their Trust, will develop speciﬁc guidelines for
anaesthetic practice which satisfy national recommenda-
tions and that these practices are audited on a regular basis.
Decontamination processes
Cleaning – removal of foreign material from an item.
This usually involves washing with a detergent to remove
contamination followed by rinsing and drying. All
organic debris, e.g. blood, tissue or body ﬂuids, must be
removed before disinfection or sterilisation, as its presence
will inhibit disinfectant or sterilant from contacting
microbial cells. Cleaning before sterilisation is of the
utmost importance in the effectiveness of decontamina-
tion procedures in reducing the risk of transmission of
prions.
Low Level Disinfection – kills most vegetative bacteria
(except TB and endospores), some fungi and some viruses
using disinfectants such as sodium hypochlorite, 70%
alcohol and chlorhexidine.
High Level Disinfection – kills vegetative bacteria (not
all endospores), fungi and viruses. With sufﬁcient contact
time (often several hours), these high level disinfectants
may produce sterilisation, e.g. the use of aldehydes,
peracetic acid and chlorine dioxide.
Sterilisation – A process used to render an object free
from viable micro-organisms, including all bacteria,
spores, fungi and viruses, with techniques such as
autoclaving (but see prions later).
Risk assessment
The choice of equipment and ⁄or the level of cleanli-
ness ⁄disinfection ⁄sterility required of re-usable items may
be assessed against the risk posed to patients of transmis-
sion of infection during any procedure in which the
equipment is employed. It has been proposed by the
MHRA Microbiology Advisory Committee that three
levels should be considered:
1 High Risk – the device will penetrate skin or
mucous membranes, enter the vascular system or a
sterile space – these devices require sterilisation.
2 Intermediate Risk – the device will be in contact
with intact mucous membranes or may become
contaminated with readily transmissible organisms –
these devices require high level disinfection or
sterilisation.
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contact patient directly – these devices require low
level disinfection or cleaning.
Infection control policy
Anaesthetic face masks
Although normally in contact with intact skin, these
items are frequently contaminated by secretions from
patients and have been implicated in causing cross-
infection [21]; local disinfection is not normally effec-
tive
. These items should be single-use items or should
be sterilised between patients by an audited Sterile
Supplies Department in accordance with the manufac-
turer’s instructions.
Airways and tubes
Oral airways, nasal airways and tracheal tubes should be
of single-use type since they readily become contam-
inated with transmissible organisms [22] and blood [23].
Ideally, supraglottic airways should be of the single-
patient use type but the re-usable design is in common
use and many anaesthetists perceive it as being less
traumatic. Therefore, a supraglottic airway designed for
repeated use should be sterilised (in an audited SSD) no
more often than the manufacturer recommends. A
supraglottic airway used for tonsillectomy or adenoid-
ectomy should not be used again (see section on Prion
Diseases). The AAGBI recommends single-use supra-
glottic airways.
Catheter mounts – angle pieces
It is recommended that these items are single-patient use
type.
Anaesthetic breathing systems
The AAGBI has previously recommended that ‘an
appropriate ﬁlter should be placed between the patient
and the breathing circuit (a new ﬁlter for each patient)’.
Although it appears that pleated hydrophobic ﬁlters
have a better ﬁltration performance than most electro-
static ﬁlters, the clinical relevance of this has yet to be
established [24, 25]. The MHRA have also warned of the
difﬁculty in assessing the performance of breathing ﬁlters
in MDA ⁄2004 ⁄013.
Until 2001 manufacturers of disposable anaesthetic
breathing circuits supplied these as non-reusable items. In
practice, most UK departments of anaesthesia used these
circuits for more than one patient or for more than one
operating session in conjunction with the use of a new
ﬁlter for each patient. In 2006, the MHRA re-emphasised
in Devices Bulletin DB 2006(04) the clinical and legal
implications of re-use of devices labelled for single use and
the AAGBI ﬁrmly supports their recommendations.
Therefore, departments may follow the manufacturer’s
recommendations for use for up to 7 days. However, to
ensure consistency in the infection control process, the
Working Party recommends that circuits are disposed of
when the anaesthetic machine and monitors are cleaned
(see below). The AAGBI recommends that anaesthetic
circuits are routinely changed on a daily basis. If
visibly contaminated or used for highly infectious cases,
e.g. tuberculosis, the circuits should be changed between
patients and safely discarded. No attempt should be made
to reprocess these items.
Anaesthetic machines
Routine daily sterilisation or disinfection of internal
components of the anaesthetic machine is not necessary if
a bacterial ⁄viral ﬁlter is used between patient and circuit.
However, manufacturers’ cleaning and maintenance pol-
icies should be followed, and bellows, unidirectional
valves and carbon dioxide absorbers should be cleaned
and disinfected periodically. All the surfaces of anaesthetic
machines and monitors should be cleaned on a daily basis
with an appropriate disinfectant or immediately if visibly
contaminated.
Laryngoscopes
As with anaesthetic facemasks, laryngoscopes are known
to become contaminated during use. Current prac-
tices for decontamination and disinfection between
patients are frequently ineffective, leaving residual
contamination that has been implicated as a source of
cross-infection [26, 27]. Blades are also regularly
contaminated with blood [28], indicating penetration
of mucous membranes, which places these items into a
high-risk category. Proper cleaning of laryngoscope
blades is of great importance before decontamina-
tion ⁄sterilisation, particularly of residue around light
sources or articulated sections. New purchases should
be of a design that is easy to clean. Although repeated
autoclaving may affect the function of laryngoscopes
[29], the Working Party recommends that re-usable
laryngoscope blades should be sterilised by an audited
SSD between patients, following the manufacturers’
instructions. Plastic sheaths may be used to cover blades
and handles to reduce contamination but it has been
noted, especially with blade covers, that these have
created difﬁculties during tracheal intubation.
There are an increasing number of inexpensive, single-
use laryngoscope blades and handles of improving design
available, and their use is to be encouraged. The choice of
blade must be dictated by Departments of Anaesthesia.
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difﬁculty is encountered.
Laryngoscope handles also become contaminated with
micro-organisms and blood during use, and they should
be washed ⁄disinfected and, if suitable, sterilised by SSDs
after every use. The knurled handles of laryngoscopes
cannot be cleaned reliably manually if covered in blood or
body ﬂuids.
Anaesthetists should show great care when handling
laryngoscopes: wear gloves during intubation and place
used instruments in a designated receptacle to prevent
contamination of surfaces, pillows and drapes.
Fibreoptic bronchoscopes
These are expensive items which cannot be autoclaved.
Decontamination is dependent on sufﬁcient contact time
with high level disinfectants and it is particularly impor-
tant that the washing and cleaning process removes all
tissue residues from the lumens. Decontamination is best
achieved with an automated system. National guidelines
for care of these instruments have been provided by the
MDA, now the MHRA, DoH and NHS Estates [18, 30,
31, and 32].
With the uncertainty of the future implications of
variant Creutzfeld Jakob Disease (CJD), these items
should have a unique identiﬁer which should be recorded
at every use to permit future tracing.
Bougies
Re-use of these items has been associated with cross-
infection [33]. Manufacturers recommend that a gum
elastic bougie may be disinfected up to ﬁve times between
patients and stored in a sealed packet. It is preferable that
alternative single-use intubation aids are employed when
possible.
Surfaces
The surfaces of anaesthetic machines and monitoring
equipment, especially those areas which are likely to
have been touched by the gloved hand that has been in
contact with blood or secretions, should be regarded as
contaminated and should be cleaned at the earliest
opportunity, probably between patients. Local policies
should be in place to ensure that all equipment that
touches intact skin, or does not ordinarily touch the
patient at all, is cleaned with a detergent at the end
of the day or whenever visibly contaminated. This
includes non-invasive blood pressure cuffs and tubing,
pulse oximeter probes and cables, stethoscopes,
electrocardiographic cables, blood warmers etc., and
the exterior of anaesthetic machines and monitors.
Items such as temperature probes should be for single
patient use.
Oxygen masks and tubing
Single-patient use products should be used.
Resuscitation equipment
Single-patient use equipment should be kept in a sealed
package or should be resterilised between patients
according to the manufacturer’s instructions. All training
equipment should be handled similarly.
5.0. Prion diseases
Transmissible Spongiform Encephalopathies (TSEs) are a
group of illnesses in which there is progressive neuro-
logical degeneration associated with characteristic path-
ological changes. TSEs are caused by abnormal prions,
which are infectious proteins. Microscopic traces of
tissue often remain on surgical instruments after washing
and autoclaving or disinfecting and any prion protein in
these traces could still transmit the disease if inoculated
into another patient. However, successive washing after
use reduces the concentration so that, after about 10
decontamination cycles, infectivity becomes negligible
[34].
Variant Creutzfeldt-Jakob disease (vCJD) is a TSE
caused by the same prion protein that causes Bovine
Spongiform Encephalopathy (BSE) in cattle. After an
incubation period of several years, the disease shows itself
as a progressive degeneration of the brain leading to
death. It is similar to sporadic CJD, which has been spread
by neurosurgical instruments, dura mater grafts and
pituitary extracts. However, while sporadic CJD prion
protein is to be found only in brain, spinal cord and
posterior eye, the prion protein of vCJD can also be
found in lymph nodes, appendix and tonsils. Prion
protein becomes detectable in tissues in the later period
of incubation and is present in higher concentrations once
the disease becomes manifest [34]. Advice on the
detection and prevention of prion diseases is available
from the Advisory Committee on Dangerous Pathogens
(ACDP), the Spongiform Encephalopathy Advisory
Committee (SEAC) and the National Institute for Health
and Clinical Excellence [35]. The CJD Incidents Panel
Advice advises on the prevention of transmission of CJD
in speciﬁc cases [36, 37].
Tonsillectomy and adenoidectomy
Lymphoid tissue, including that of the adenoid and tonsil,
is of ‘medium infectivity’ for vCJD and it is possible that a
patient undergoing surgery could be incubating this
disease. Surgeons routinely operate with traceable reus-
able instruments in accord with latest national advice,
since single-use instruments were associated with exces-
sive bleeding and risks of CJD transfer are low [38].
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should be destroyed after use for these operations as they
can be contaminated by infectious tissue and batch
cleaning may cause transfer of protein from one device
to another [39].
Theoretically, a laryngoscope blade used at the end of
surgery or for emergency re-intubation could become
contaminated. However, the Working Party’s estimate is
that the risk is extremely small and probably less than
those posed by the use of a disposable laryngoscope for
what could be a difﬁcult laryngoscopy. Therefore, the
recommendation is that single-use laryngoscopes are
not mandatory in anaesthesia for tonsil and adenoid
surgery. Those purchasing laryngoscopes with single-use
blades (and other single-use devices) have a responsibility
to ensure that the performance of the instruments is at
least as good as that of the standard reusable alternatives.
Anaesthetic management of cases of CJD
This advice covers known cases, suspected cases and those
who are at risk of developing CJD. Isolation is not
needed. Standard (‘universal’) precautions are essential.
Blood and other samples should be labelled ‘Biohazard’.
Invasive procedures such as central venous cannulation
and spinal anaesthesia mandate the use of full aseptic
procedures, including mask and eye protection. The area
around where invasive procedures are performed should
be clear enough to allow easy mopping of spillages. High
infectivity tissues are those in the brain, spinal cord and
posterior eye; medium risk tissues for CJD are those in the
anterior eye and olfactory epithelium – any needles or
probes used by anaesthetists near these tissues will be
disposable. In vCJD, lymphoid tissue is also classed as
having medium infectivity. In these circumstances, it is
advisable that any laryngoscope used after the tonsil has
been operated on or any bronchoscope used for biopsy on
patients in this group should be treated as potentially
contaminated. These instruments should either be
destroyed (easily done with single-use laryngoscopes) or
should be quarantined pending advice. Such advice can
be obtained from the CJD Incidents Panel.
Transmission of vCJD by transfusion of blood
and blood products
Although only three cases have been discovered, this is
the only route of transfer of vCJD as yet shown to be
from medical interventions. The National Blood Trans-
fusion Service repeatedly updates its procedures so as to
reduce the tiny risk of transfer of prions, viruses and
bacteria [40]. Procedures include leucodepletion and
sourcing most plasma products from outside the UK.
Anaesthetists can further decrease the risk by minimising
the use of blood and blood products.
Summary: how to reduce the risk of transmission
of prion disease
1 Adherence to the same universal precautions as for
other potential infections.
2 Minimising the use of transfusion of blood and blood
products.
3 Use of SSD decontamination and sterilisation with
tracing for all reusable equipment.
4 Ensuring that any instrument that contacts the brain,
spinal cord or dura is destroyed afterwards.
5 The employment of single-use equipment when this is
as reliable and safe as the re-usable alternatives.
6 Destroying or quarantining instruments used on cases
who may have CJD and for those known to be at risk.
7 Ensuring that all airway devices used during tonsillec-
tomy and adenoidectomy are discarded after use.
6.0. Infection control precautions for
anaesthetic procedures
Carrying out procedures in an operating theatre does not
pose a lower risk of infection than other hospital locations
and the risk of infection depends on the procedure and on
the level of barrier protection rather than the surrounding
environment [41].
Maximal barrier precautions
Maximal barrier precautions involve full hand washing,
the wearing of sterile gloves and gown, a cap, mask and
the use of a large sterile drape [42]. The skin entry site
should be cleaned with an alcoholic chlorhexidine
gluconate solution or alcoholic povidone-iodine solution
[43]. The antiseptic should be allowed to dry before
proceeding.
Certain invasive anaesthetic procedures require this
optimum aseptic technique:
• Insertion of central venous catheters.
• Spinal, epidural and caudal procedures.
The Working Party is aware that many anaesthetists do
not employ this level of asepsis for ‘one-shot’ spinals or
epidurals but believes that, when central neural spaces are
penetrated, full aseptic precautions are required.
Comprehensive guidelines have been prepared for
insertion and maintenance of central venous catheters
[44] and are commended to all anaesthetists. The use of
care bundles has been advocated by IHI (Institute of
Health Improvement) to reduce catheter related bacte-
raemias. Originally developed in the USA, Care Bundles
is an approach that systematically appraises clinical
processes. It is based on measuring the actual provision
of therapeutic interventions according to standards,
informed by evidence, which local clinicians set them-
selves [45].
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Certain invasive procedures do not require full barrier
precautions as above but nevertheless demand appropriate
aseptic techniques. Such precautions involve the wearing
of sterile gloves and use of small drapes, although similar
attention is required to hand washing and skin prepara-
tion. These procedures include:
• Peripheral regional blocks.
• Arterial line insertion.
Peripheral venepuncture or intramuscular injection in
low-risk patients will involve handwashing, non-sterile
gloves and skin preparation with propyl alcohol. Periph-
eral intravenous catheters are a signiﬁcant source of
nosocomial bacteraemias and care is required.
High-risk patients
Certain patients may be especially vulnerable to infection,
e.g. the immunocompromised, or offer particularly high
risk of transmitting infection, e.g. tuberculosis and HIV.
For the immunocompromised, maximal barrier precau-
tions are required for all invasive procedures and similarly,
where there is a high infection risk, staff should concen-
trate not only on preventing cross-infection between
patients but in protecting themselves by ensuring com-
pliance with all precautions.
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